The efficacy and safety of direct oral anticoagulants in patients with chronic renal insufficiency: A review of the literature-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The efficacy and safety of direct oral anticoagulants in patients with chronic renal insufficiency: A review of the literature

Published:2019-02-07 Issue:4 Volume:102 Page:312-318
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Weber Jacob¹,Olyaei Ali²³,Shatzel Joseph¹^ORCID

Affiliation:

1. The Division of Hematology & Oncology, School of Medicine, Knight Cancer Institute; Oregon Health & Science University; Portland Oregon

2. Department of Medicine, Nephrology and Hypertension; Oregon Health & Science University; Portland Oregon

3. Department of Pharmacy Practice, College of Pharmacy; Oregon State University; Corvallis Oregon

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13208/fullpdf

Reference25 articles.

1. Nonvitamin K anticoagulant agents in patients with advanced chronic kidney disease or on dialysis with AF;Chan;J Am Coll Cardiol,2016

2. Risks and benefits of direct oral anticoagulants across the spectrum of GFR among incident and prevalent patients with atrial fibrillation;Shin;Clin J Am Soc Nephrol,2018

3. Outcomes associated with apixaban use in end-stage kidney disease patients with atrial fibrillation in the United States;Siontis;Circulation,2018

4. Clinical application and pharmacodynamic monitoring of apixaban in a patient with end-stage renal disease requiring chronic hemodialysis;Kufel;Pharmacotherapy,2016

5. Direct oral anticoagulants-pharmacology, drug interactions, and side effects;Dempfle;Semin Hematol,2014

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience;Internal and Emergency Medicine;2024-06-28

2. Evaluation of Apixaban Use in Patients With Advanced Kidney Disease;Journal of Pharmacy Technology;2024-04-27

3. A real-world exploration into clinical outcomes of direct oral anticoagulant therapy in people with chronic kidney disease: a large hospital-based study;Journal of Nephrology;2024-04-02

4. The importance of intensive follow-up and achieving optimal chronic antithrombotic treatment in hospitalized medical patients with anemia: a prospective cohort study;Hellenic Journal of Cardiology;2024-01

5. Foldable low-cost point-of-care device for testing blood coagulation using smartphones;Biosensors and Bioelectronics;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3